• OPEN AN ACCOUNT
Indian Indices
Nifty
24,680.90 -156.10
(-0.63%)
Sensex
80,924.28 33.26
( 0.04%)
Bank Nifty
56,084.90 -444.00
( -0.79%)
Nifty IT
35,370.05 -253.70
( -0.71%)
Global Indices
Nasdaq
44,851.29 -71.64
(-0.16%)
Dow Jones
6,409.51 -0.13
(0.00%)
Hang Seng
41,045.60 -410.63
(-0.99%)
Nikkei 225
9,081.44 -38.87
(-0.43%)
Forex
USD-INR
86.51 0.12
(0.14%)
EUR-INR
101.58 -0.03
(-0.03%)
GBP-INR
116.22 -0.77
(-0.66%)
JPY-INR
0.59 0.00
(-0.62%)

EQUITY - MARKET SCREENER

Hester Biosciences Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524669
INE782E01017
398.6037923
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
HESTERBIO
47.88
1541.15
EPS(TTM)
Face Value()
Div & Yield %
37.84
10
0.39
 

Elitecon International standalone net profit rises 93.81% in the March 2025 quarter
May 28,2025
Net profit of Elitecon International rose 93.81% to Rs 12.21 crore in the quarter ended March 2025 as against Rs 6.30 crore during the previous quarter ended March 2024. Sales rose 170.65% to Rs 120.41 crore in the quarter ended March 2025 as against Rs 44.49 crore during the previous quarter ended March 2024.

For the full year,net profit rose 573.85% to Rs 32.21 crore in the year ended March 2025 as against Rs 4.78 crore during the previous year ended March 2024. Sales rose 423.60% to Rs 297.51 crore in the year ended March 2025 as against Rs 56.82 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales120.4144.49 171 297.5156.82 424
OPM %10.0315.67 -10.6412.78 -
PBDT12.736.38 100 33.936.86 395
PBT12.196.23 96 32.134.65 591
NP12.216.30 94 32.214.78 574